Gate Bioscience

Brisbane, CA · Founded 2021 · Privately Held (backing)

Developer of small molecule drugs designed to selectively eliminate harmful extracellular proteins at their origin, inside cells, and prevent them from emerging to cause disease. Gate Bioscience is based in Brisbane, CA and was founded in 2021. Its last reported valuation was $161 million in Nov 2025. It has raised $135 million.

Last reported valuation

$161.0M

Oct 2026

Priced at

—

Total raised

$134.5M

Last round

—

How much has Gate Bioscience raised?

$134.5Macross 0 recorded rounds

Free account

More of Gate Bioscience with a free account

·Watch Gate Bioscience: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Gate Bioscience investors

6 investors are on record for Gate Bioscience, including Andreessen Horowitz, GV, ARCH Venture Partners and Forbion. By type, the record holds 5 venture capital firms.

For fundraisers

Raising for a company like Gate Bioscience?

6 investors have backed Gate Bioscience.

See all 6 investors →

Frequently asked about Gate Bioscience

How much has Gate Bioscience raised?: Gate Bioscience has raised $134.5M in total across 0 recorded funding rounds.